|
|
||||||||
The FASEB Journal, Vol 11, 1157-1168, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
P Durand, S Lussier-Cacan and D Blache
INSERM CJF 93-10, Laboratoire de Biochimie des Lipoproteines, Faculte de Medecine, Universite de Bourgogne, Dijon, France.
A moderate elevation of plasma homocysteine is a risk factor for atherosclerosis and arterial and veinous thrombosis. However, the mechanisms leading to vascular disorders are poorly understood because studies that have investigated the potential atherothrombogenicity of hyperhomocysteinemia in vivo are scarce. Using a rat model, we were the first to show that dietary folic acid deficiency, a major cause of basal hyperhomocysteinemia, is associated with enhanced macrophage- derived tissue factor and platelet activities. We proposed that an homocysteine-induced oxidative stress may account for this hypercoagulable state. To determine the true thrombogenicity of moderate hyperhomocysteinemia and better understand its etiology, we have carried out an acute methionine load in control and folate- deficient animals. When rats were fed the control diet, a transient fourfold increase in plasma homocysteine levels was observed 2 h after the methionine administration. As with prolonged dietary folic acid deficiency, this methionine load potentiated the platelet aggregation in response to thrombin and ADP as well as the thrombin-induced thromboxane synthesis. It also stimulated the basal and lipopolysaccharide-induced tissue factor activity of peritoneal macrophages. These prothrombotic effects were associated with an increased lipid peroxidation characterized by an elevation of plasma conjugated dienes, lipid hydroperoxides, and thiobarbituric acid- reactive substances. When rats were fed a folic acid-deficient diet, the methionine load did not cause any further increase in plasma homocysteine concentration, platelet activation, macrophage tissue factor-dependent coagulation, or lipoperoxidation. Altogether, our data showed that the prethrombotic state due to both the altered remethylation and transsulfuration pathways resulted from the moderate elevation of circulating homocysteine. We conclude that moderate hyperhomocysteinemia plays a role in the development of a thrombogenic state that might be mediated by the occurrence of oxidative stress.
This article has been cited by other articles:
![]() |
A. L. Moens, C. J. Vrints, M. J. Claeys, J.-P. Timmermans, H. C. Champion, and D. A. Kass Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1971 - H1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Stangl, K. Weisse, C. Dinger, F. Hirche, C. Brandsch, and K. Eder Homocysteine Thiolactone-Induced Hyperhomocysteinemia Does Not Alter Concentrations of Cholesterol and SREBP-2 Target Gene mRNAs in Rats Experimental Biology and Medicine, January 1, 2007; 232(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Fukada, M. Setoue, T. Morita, and K. Sugiyama Dietary Eritadenine Suppresses Guanidinoacetic Acid-Induced Hyperhomocysteinemia in Rats J. Nutr., November 1, 2006; 136(11): 2797 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ide, C. Keller, and N. Weiss Aged Garlic Extract Inhibits Homocysteine-Induced CD36 Expression and Foam Cell Formation in Human Macrophages J. Nutr., March 1, 2006; 136(3): 755S - 758S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brasselet, R. Garnotel, A. Lafont, S. Perotin, F. Vitry, E. Durand, L. Ducher, J. Elaerts, D. Metz, and P. Gillery Prepercutaneous Coronary Intervention Plasma Homocysteine Concentration Is a Useful Predictor of Angioplasty-Induced Myocardial Damage Clin. Chem., December 1, 2005; 51(12): 2374 - 2377. [Full Text] [PDF] |
||||
![]() |
K. L Tucker, B. Olson, P. Bakun, G. E Dallal, J. Selhub, and I. H Rosenberg Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial Am. J. Clinical Nutrition, May 1, 2004; 79(5): 805 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bozkurt, S. Keles, M. Acikel, M. Islek, and S. Atesal Plasma Homocysteine Level and the Angiographic Extent of Coronary Artery Disease Angiology, May 1, 2004; 55(3): 265 - 270. [Abstract] [PDF] |
||||
![]() |
R. Zhang, J. Ma, M. Xia, H. Zhu, and W. Ling Mild Hyperhomocysteinemia Induced by Feeding Rats Diets Rich in Methionine or Deficient in Folate Promotes Early Atherosclerotic Inflammatory Processes J. Nutr., April 1, 2004; 134(4): 825 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matetzky, D. Freimark, S. Ben-Ami, I. Goldenberg, J. Leor, R. Doolman, I. Novikov, M. Eldar, and H. Hod Association of Elevated Homocysteine Levels With a Higher Risk of Recurrent Coronary Events and Mortality in Patients With Acute Myocardial Infarction Arch Intern Med, September 8, 2003; 163(16): 1933 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Ebbesen, K. Christiansen, and J. Ingerslev Hyperhomocysteinemia Due to Folate Deficiency Is Thrombogenic in Rats J. Nutr., July 1, 2003; 133(7): 2250 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wang, C. W.H. Woo, F. L. Sung, Y. L. Siow, and K. O Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia: Role of Chemokine and Adhesion Molecules Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1777 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF] |
||||
![]() |
M.-C. Beauchamp and G. Renier Homocysteine Induces Protein Kinase C Activation and Stimulates c-Fos and Lipoprotein Lipase Expression in Macrophages Diabetes, April 1, 2002; 51(4): 1180 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Bagi, Z. Ungvari, and A. Koller Xanthine Oxidase-Derived Reactive Oxygen Species Convert Flow-Induced Arteriolar Dilation to Constriction in Hyperhomocysteinemia: Possible Role of Peroxynitrite Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 28 - 33. [Abstract] [Full Text] |
||||
![]() |
J. Zhou, J. Moller, C. C. Danielsen, J. Bentzon, H. B. Ravn, R. C. Austin, and E. Falk Dietary Supplementation With Methionine and Homocysteine Promotes Early Atherosclerosis but Not Plaque Rupture in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1470 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Bagi, Z. Ungvari, L. Szollar, and A. Koller Flow-Induced Constriction in Arterioles of Hyperhomocysteinemic Rats Is Due to Impaired Nitric Oxide and Enhanced Thromboxane A2 Mediation Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 233 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Duan, T. Murohara, H. Ikeda, K.-i. Sasaki, S. Shintani, T. Akita, T. Shimada, and T. Imaizumi Hyperhomocysteinemia Impairs Angiogenesis in Response to Hindlimb Ischemia Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2579 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khajuria and D. S. Houston Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis Blood, August 1, 2000; 96(3): 966 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J Milionis, A. F Winder, and D. P Mikhailidis Lipoprotein (a) and stroke J. Clin. Pathol., July 1, 2000; 53(7): 487 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari, E. Sarkadi-Nagy, Z. Bagi, L. Szollar, and A. Koller Simultaneously Increased TxA2 Activity in Isolated Arterioles and Platelets of Rats With Hyperhomocysteinemia Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1203 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Al-Obaidi, H. Philippou, P. J. Stubbs, A. Adami, R. Amersey, M. M. Noble, and D. A. Lane Relationships Between Homocysteine, Factor VIIa, and Thrombin Generation in Acute Coronary Syndromes Circulation, February 1, 2000; 101(4): 372 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fonseca, S. C. Guba, and L. M. Fink Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis Endocr. Rev., October 1, 1999; 20(5): 738 - 759. [Abstract] [Full Text] |
||||
![]() |
K. J. Harjai Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen Ann Intern Med, September 7, 1999; 131(5): 376 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari, P. Pacher, K. Rischak, L. Szollar, and A. Koller Dysfunction of Nitric Oxide Mediation in Isolated Rat Arterioles With Methionine Diet–Induced Hyperhomocysteinemia Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1899 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Voutilainen, J. D. Morrow, L. J. Roberts II, G. Alfthan, H. Alho, K. Nyyssonen, and J. T. Salonen Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1263 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. BOURDON, N. LOREAU, and D. BLACHE Glucose and free radicals impair the antioxidant properties of serum albumin FASEB J, February 1, 1999; 13(2): 233 - 244. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |